Editorial
doi: 10.1093/jnci/djh191.
Tamoxifen: Dr. Jekyll and Mr. Hyde?
- PMID: 15199102
- DOI: 10.1093/jnci/djh191
Item in Clipboard
Editorial
Tamoxifen: Dr. Jekyll and Mr. Hyde?
J Natl Cancer Inst.
.
No abstract available
Comment on
-
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.J Natl Cancer Inst. 2004 Jun 16;96(12):926-35. doi: 10.1093/jnci/djh166. J Natl Cancer Inst. 2004. PMID: 15199112
Similar articles
-
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.J Natl Cancer Inst. 2004 Jun 16;96(12):926-35. doi: 10.1093/jnci/djh166. J Natl Cancer Inst. 2004. PMID: 15199112
-
Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer.Am J Clin Oncol. 2005 Dec;28(6):631-3. doi: 10.1097/01.coc.0000182412.83562.76. Am J Clin Oncol. 2005. PMID: 16317277 No abstract available.
-
The nature of tamoxifen action in the control of female breast cancer.In Vivo. 2001 Jul-Aug;15(4):319-25. In Vivo. 2001. PMID: 11695224 Review.
-
Is tamoxifen the Rosetta stone for breast cancer?J Natl Cancer Inst. 2003 Mar 5;95(5):338-40. doi: 10.1093/jnci/95.5.338. J Natl Cancer Inst. 2003. PMID: 12618491 Review. No abstract available.
-
A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer.Dokl Biochem Biophys. 2007 Mar-Apr;413:83-7. doi: 10.1134/s1607672907020123. Dokl Biochem Biophys. 2007. PMID: 17546960 No abstract available.
Cited by
-
Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive Cancer Cells via Activating Mutations.J Oncol. 2020 Jul 28;2020:5418365. doi: 10.1155/2020/5418365. eCollection 2020. J Oncol. 2020. PMID: 32774370 Free PMC article. Review.
-
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.Breast Cancer Res. 2006;8(6):R73. doi: 10.1186/bcr1631. Breast Cancer Res. 2006. PMID: 17196107 Free PMC article.
-
Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens.Oncol Rev. 2023 Apr 19;17:10708. doi: 10.3389/or.2023.10708. eCollection 2023. Oncol Rev. 2023. PMID: 37152665 Free PMC article. Review.
-
The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance.Drug Des Devel Ther. 2015 Aug 6;9:4341-53. doi: 10.2147/DDDT.S89536. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273195 Free PMC article.
-
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery.Recent Pat Anticancer Drug Discov. 2016;11(3):254-66. doi: 10.2174/1574892811666160415160211. Recent Pat Anticancer Drug Discov. 2016. PMID: 27087654 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
